1 citations
,
January 2014 in “Progress in Neurology and Psychiatry” Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.
1 citations
,
January 2002 in “Dermatology + psychosomatics” Most people worried about abnormal hair loss actually have psychological issues like depression or anxiety.
May 2026 in “Research Square” Children with alopecia areata often face more stress and depression, especially related to separation, which can affect their condition.
May 2026 in “Indian Journal of Medical Biochemistry” Hair biomarkers can help assess chronic stress in women's reproductive health but need standardized methods and regional studies.
March 2026 in “Actas Dermo-Sifiliográficas” Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.
February 2026 in “Journal of Dermatology and Skin Science” Finasteride can cause serious mental health issues, so it's advised to avoid it for hair loss.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Alopecia affects mental health, causing depression and anxiety, but new treatments can improve both hair growth and quality of life.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.
February 2026 in “Research Society and Development” PCOS is a common disorder in women causing symptoms like irregular periods and infertility, and requires early diagnosis and treatment.
February 2026 in “NeuroSci” Finasteride and dutasteride may cause depression and anxiety, especially in younger men.
February 2026 in “BMJ Open” A multidisciplinary approach is crucial for supporting the well-being of people with alopecia areata.
January 2026 in “SKIN The Journal of Cutaneous Medicine” Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.
January 2026 in “Advances in Dermatology and Allergology” Stress significantly affects the quality of life in patients with lichen planopilaris and frontal fibrosing alopecia.
December 2025 in “PLOS Global Public Health” Women with PCOS in Bangladesh face significant mental health issues, especially in rural areas.
December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.
December 2025 in “International Journal of Research in Dermatology” Isotretinoin effectively treats severe acne but has serious side effects and requires careful monitoring.
December 2025 in “The Journal of Clinical Psychiatry” Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.
December 2025 in “The Journal of Clinical Psychiatry” Finasteride can cause depression and suicidal thoughts; safer alternatives are recommended.
November 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” Androgenetic alopecia negatively impacts mental health, suggesting a need for psychological support in treatment.
Finasteride can help with hair loss but may cause mental health issues like depression and anxiety.
November 2025 in “Gynecological Endocrinology” This narrative review addresses the management of polycystic ovary syndrome (PCOS) by proposing pragmatic strategies across different levels of care. It emphasizes the importance of managing menstrual irregularities in primary care using oral contraceptives or progestins, with referrals for fertility or complex cases. Dermatological symptoms like hirsutism and acne may need topical or hormonal treatments, escalating to anti-androgens or dermatology specialists if necessary. Routine screening for cardiometabolic and glycaemic risks should occur in general practice, with specialist referrals for complex profiles. Emotional wellbeing, including anxiety, depression, and body image issues, can be initially screened in primary care with validated questionnaires, followed by referrals as needed. The review concludes that effective PCOS management requires clear role delineation between primary and specialist care, integration of digital tools, and patient-centered education to enhance efficiency and outcomes.
November 2025 in “Psychoneuroendocrinology” Hair proteomics could be a useful, non-invasive tool for identifying stress-related disorders.
October 2025 in “Reactions Weekly” Finasteride and dutasteride may cause depression and suicidal thoughts.
September 2025 in “Journal of Cosmetic Dermatology” Hair transplantation improves self-esteem and social confidence, but managing expectations and psychological risks is crucial for success.
September 2025 in “International Journal of Innovative Technologies in Social Science” Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.
August 2025 in “Brazilian Journal of Hair Health” Hair-related body dysmorphic disorder is common in hair loss patients and needs early recognition for proper treatment.
August 2025 in “Annals of Indian Psychiatry” Hair loss can affect mood, self-esteem, body image, and quality of life.
July 2025 in “International Journal of Dermatology” Topical finasteride may be safer than oral finasteride, but more research is needed.
June 2025 in “Journal of Cosmetic Dermatology” Alopecia areata is linked to higher anxiety and depression, especially in younger women in certain countries.
June 2025 in “British Journal of Dermatology” Hair loss in women causes emotional distress and low self-esteem, but supportive interventions can help.